Quest Diagnostics Reports Third Quarter 2016 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Quest Diagnostics (DGX) Tops Q3 EPS by 2c; Narrows FY16 Outlook
October 20, 2016 6:46 AM EDTQuest Diagnostics (NYSE: DGX) reported Q3 EPS of $1.37, $0.02 better than the analyst estimate of $1.35. Revenue for the quarter came in at $1.89 billion versus the consensus estimate of $1.89 billion.
GUIDANCE:
Quest Diagnostics sees FY2016 EPS of $5.07-$5.12, versus prior guidance of... More



